Kratom laws in Pennsylvania

(9) Intoxicating Substance. Any Intoxicating Hemp Product or Kratom Product.
(10) "Kratom Extract." A food product that contains any part of a leaf from mitragyna
speciosa, commonly known as kratom, which has been extracted and concentrated to provide more
standardized dosing.
(11) Kratom Product. Any intermediate or final product that is intended for human or
animal use through any means of application or administration, such as inhalation or ingestion,
and contains in any form mitragynine or 7 hydroxymitragynine that is:
(a) derived from any part of Mitragyna speciosa plant, including the seeds
thereof and all derivatives, extracts, alkaloids, isomers, and compounds, whether growing or not;
(b) not capable of being naturally produced by a Mitragyna speciosa plant;
or
(c) capable of being naturally produced by a Mitragyna speciosa plant and
was synthesized or manufactured outside the plant.
...
§ 9-6702. Prohibition on Sales.
(1) It shall be unlawful for any person to sell or offer for sale any substance set forth in
the Exclusions from the definition of Hemp under the Agricultural Marketing Act of 1946 (7 U.S.C.
§ 1639o).
(2) It shall be unlawful for any person to sell or offer for sale any kratom product that
meets any of the following criteria:
(a) Is mixed or packed with a nonkratom substance that affects the quality or
strength of the kratom product to such a degree as to render the kratom product injurious to a
consumer;
(b) Contains a kratom extract with levels of residual solvents higher than the
standards specified in the edition of the United States Pharmacopeia/National Formulary 467 that
is current on the effective date of this paragraph;
(c) Contains a level of 7-hydroxymitragynine in the alkaloid fraction that is
greater than 2 percent of the overall alkaloid composition of the kratom product; or
(d) Contains a synthetic alkaloid, including a synthetic mitragynine, a
synthetic 7-hydroxymitragynine or any other synthetically derived compounds of the kratom plant.
(3) It shall be unlawful for any person to sell or offer for sale any intoxicating
substance that is not considered appropriate for use as a dietary supplement or a safe food additive
or the subject of an application that has been approved
...
(4) It shall be unlawful for any person to sell or offer for sale any intoxicating
substance to any individual under twenty-one (21) years of age.
...
SECTION 2. This Ordinance shall be effective November 12, 2026, except that Section 9-6703
("Permitted Sale of Intoxicating Substances") shall take effect upon the issuance of regulations by
the Department.

(9) Intoxicating Substance. Any Intoxicating Hemp Product or Kratom Product.
(10) "Kratom Extract." A food product that contains any part of a leaf from mitragyna
speciosa, commonly known as kratom, which has been extracted and concentrated to provide more
standardized dosing.
(11) Kratom Product. Any intermediate or final product that is intended for human or
animal use through any means of application or administration, such as inhalation or ingestion,
and contains in any form mitragynine or 7 hydroxymitragynine that is:
(a) derived from any part of Mitragyna speciosa plant, including the seeds
thereof and all derivatives, extracts, alkaloids, isomers, and compounds, whether growing or not;
(b) not capable of being naturally produced by a Mitragyna speciosa plant;
or
(c) capable of being naturally produced by a Mitragyna speciosa plant and
was synthesized or manufactured outside the plant.
...
§ 9-6702. Prohibition on Sales.
(1) It shall be unlawful for any person to sell or offer for sale any substance set forth in
the Exclusions from the definition of Hemp under the Agricultural Marketing Act of 1946 (7 U.S.C.
§ 1639o).
(2) It shall be unlawful for any person to sell or offer for sale any kratom product that
meets any of the following criteria:
(a) Is mixed or packed with a nonkratom substance that affects the quality or
strength of the kratom product to such a degree as to render the kratom product injurious to a
consumer;
(b) Contains a kratom extract with levels of residual solvents higher than the
standards specified in the edition of the United States Pharmacopeia/National Formulary 467 that
is current on the effective date of this paragraph;
(c) Contains a level of 7-hydroxymitragynine in the alkaloid fraction that is
greater than 2 percent of the overall alkaloid composition of the kratom product; or
(d) Contains a synthetic alkaloid, including a synthetic mitragynine, a
synthetic 7-hydroxymitragynine or any other synthetically derived compounds of the kratom plant.
(3) It shall be unlawful for any person to sell or offer for sale any intoxicating
substance that is not considered appropriate for use as a dietary supplement or a safe food additive
or the subject of an application that has been approved
...
(4) It shall be unlawful for any person to sell or offer for sale any intoxicating
substance to any individual under twenty-one (21) years of age.
...
SECTION 2. This Ordinance shall be effective November 12, 2026, except that Section 9-6703
("Permitted Sale of Intoxicating Substances") shall take effect upon the issuance of regulations by
the Department.

(89) Methyl (E)-2-((1'S,6'S,7'S)-6'-ethyl-4-methoxy-3-oxo- 9672
3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-2,1'-
indolizine]-7'-yl)-3-methoxyacrylate (commonly known as
mitragynine pseudoindoxyl) including its isomers, esters,
...
(90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8- 9673
...
15; also known as dihydro-7-hydroxymitragynine) including its
...
(91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a- 9674
...
(commonly known as MGM-16; also known as 9-fluoro-dihydro-7-
hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine

The substances [7-hydroxymitragynine] and [mitragynine
pseudoindoxyl] be controlled in schedule I [pursuant to 21 U.S.C.
811(h)] when either substance alone, or their combined amount if both
present, is:
(A) Above a specified threshold concentration, that is, greater
than 1 mg per gram (for solid powders, encapsulated material, or other
solid forms) or greater than 1 mg per milliliter (for liquid
preparations), OR
(B) The mass of mitragynine present divided by the mass of [7-
hydroxymitragynine], or [mitragynine pseudoindoxyl], or the combined
amount of [7-hydroxymitragynine] and [mitragynine pseudoindoxyl] if
both present, is less than 100.
...
The temporary scheduling order will be published in the Federal
Register on or after November 13, 2026.